Prana Biotechnology Limited (PRAN) Reaches $2.07 After 6.00% Up Move; Forescout Technologies (FSCT) Shorts Increased By 24.63%

June 14, 2018 - By Charlene Higgins

The stock of Prana Biotechnology Limited (NASDAQ:PRAN) is a huge mover today! The stock increased 7.25% or $0.14 during the last trading session, reaching $2.07. About 70,550 shares traded or 155.38% up from the average. Prana Biotechnology Limited (NASDAQ:PRAN) has risen 0.42% since June 14, 2017 and is uptrending. It has underperformed by 12.15% the S&P500.The move comes after 6 months positive chart setup for the $19.47 million company. It was reported on Jun, 14 by We have $2.19 PT which if reached, will make NASDAQ:PRAN worth $1.17M more.

Forescout Technologies Inc (NASDAQ:FSCT) had an increase of 24.63% in short interest. FSCT’s SI was 229,700 shares in June as released by FINRA. Its up 24.63% from 184,300 shares previously. With 854,500 avg volume, 0 days are for Forescout Technologies Inc (NASDAQ:FSCT)’s short sellers to cover FSCT’s short positions. The SI to Forescout Technologies Inc’s float is 1.41%. The stock increased 3.10% or $1.0699 during the last trading session, reaching $35.5699. About 793,405 shares traded or 30.00% up from the average. ForeScout Technologies, Inc. (NASDAQ:FSCT) has 0.00% since June 14, 2017 and is . It has underperformed by 12.57% the S&P500. Some Historical FSCT News: ; 13/04/2018 – Cramer vets under-the-radar cybersecurity plays like ForeScout; 14/05/2018 – ForeScout Technologies at JPMorgan Conference Tomorrow; 20/03/2018 – FORESCOUT TECHNOLOGIES REPORTS PRICING OF FOLLOW-ON OFFERING; 18/04/2018 – Global Network Access Control (NAC) Market (2018-2022) Projected to Grow at a CAGR of 27.23% – Key Vendors are Cisco, ForeScout Technologies, and HPE –; 10/05/2018 – Forescout Technologies Sees FY18 Adj Loss/Shr $1.08-Adj Loss/Shr $1; 10/05/2018 – Forescout Technologies 1Q Rev $59.7M; 19/03/2018 – ForeScout Technologies Announces Launch of Proposed Follow-on Offering; 11/05/2018 – FORESCOUT TECHNOLOGIES INC FSCT.O : MORGAN STANLEY RAISES TARGET PRICE TO $34 FROM $31; 09/04/2018 – ForeScout Sweeps CRN Awards in IoT and Security; 10/05/2018 – Forescout Technologies Sees 2Q Rev $61M-$64M

Another recent and important Prana Biotechnology Limited (NASDAQ:PRAN) news was published by which published an article titled: “Prana Biotech (PRAN) Announces Initiation of Phase 1 Clinical Trial of PBT434 for Treatment of Parkinsonian Diseases” on June 14, 2018.

Prana Biotechnology Limited develops therapies for the treatment of Alzheimer's disease, Huntington disease, and other neurodegenerative disorders in Australia. The company has market cap of $19.47 million. The Company’s lead drug candidates include PBT2, which is in Phase IIb clinical trials for the treatment of AlzheimerÂ’s: and that is in Phase IIa clinical trials for the treatment of HuntingtonÂ’s diseases. It currently has negative earnings. The firm is also developing PBT434, which is in preclinical toxicology stage for the treatment for ParkinsonÂ’s disease and other movement disorders; and PBT 519 that is in preclinical toxicology stage for the treatment of brain cancer.

Among 2 analysts covering Prana Biotechnology Ltd (NASDAQ:PRAN), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Prana Biotechnology Ltd had 2 analyst reports since January 5, 2018 according to SRatingsIntel.

ForeScout Technologies, Inc. provides network security hardware and software products in the United States, Europe, the Middle East, Africa, the Asia Pacific, and Japan. The company has market cap of $1.43 billion. It offers ForeScout CounterACT agentless technology that discovers, classifies, and assesses IP devices; ForeScout extended modules for integrations across vulnerability assessment, advanced threat detection, security incidence and event management, enterprise mobility management, endpoint protection and endpoint detection and response, next generation firewall, privileged access management, and IT systems management vendors, as well as compliance; and ForeScout CounterACT Enterprise Manager, a centralized security management solution for the control of various appliances deployed on an end-customer network, as well as maintenance and professional services. It currently has negative earnings. The companyÂ’s products are used to protect organizations against the threats that exploit the billions of Internet of things devices connected to organizationsÂ’ networks.

More important recent ForeScout Technologies, Inc. (NASDAQ:FSCT) news were published by: which released: “ForeScout Deepens Visibility into Operational Technology Networks with New Industrial System Integrations” on June 13, 2018, also published article titled: “ForeScout Technologies: Securing The Internet Of Things”, published: “Indegy Partners with ForeScout to Eliminate OT Network Blindspots” on June 13, 2018. More interesting news about ForeScout Technologies, Inc. (NASDAQ:FSCT) was released by: and their article: “New Research Coverage Highlights Franklin Electric Co., ForeScout Technologies, State Bank Financial, Meta …” with publication date: May 25, 2018.

ForeScout Technologies, Inc. (NASDAQ:FSCT) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: